<bill session="115" type="h" number="3964" updated="2023-01-11T13:38:28Z">
  <state datetime="2017-10-05">REFERRED</state>
  <status>
    <introduced datetime="2017-10-05"/>
  </status>
  <introduced datetime="2017-10-05"/>
  <titles>
    <title type="display">Opioid Addiction Prevention Act of 2017</title>
    <title type="short" as="introduced">Opioid Addiction Prevention Act of 2017</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="R000582"/>
  <cosponsors>
    <cosponsor bioguide_id="B000574" joined="2018-02-13"/>
    <cosponsor bioguide_id="C001105" joined="2018-02-26"/>
    <cosponsor bioguide_id="F000465" joined="2018-01-19"/>
    <cosponsor bioguide_id="G000582" joined="2017-10-05"/>
    <cosponsor bioguide_id="K000382" joined="2017-10-05"/>
    <cosponsor bioguide_id="M001193" joined="2017-10-05"/>
    <cosponsor bioguide_id="N000188" joined="2018-02-06"/>
    <cosponsor bioguide_id="P000611" joined="2018-02-13"/>
    <cosponsor bioguide_id="R000600" joined="2017-10-05"/>
    <cosponsor bioguide_id="S001170" joined="2018-01-29"/>
    <cosponsor bioguide_id="S001196" joined="2018-01-10"/>
    <cosponsor bioguide_id="T000467" joined="2018-01-10"/>
  </cosponsors>
  <actions>
    <action datetime="2017-10-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-10-05" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-05">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-06">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-10-16">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="h" number="4408" relation="unknown"/>
    <bill session="115" type="s" number="892" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health personnel"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-03-29T21:09:07Z" status="Introduced in House">Opioid Addiction Prevention Act of 2017

This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to comply with certain requirements when prescribing opioids for the initial treatment of acute pain, such as a limit on the initial supply.

An opioid that is approved and prescribed for the treatment of addiction is not subject to the requirements.</summary>
</bill>
